Virpax Pharmaceuticals announces 1-for-10 reverse stock split

Virpax Pharmaceuticals announced that it will effect a 1-for-10 reverse stock split of its common stock, par value $0.001 per share, that will become effective at 12:01 a.m. Eastern Time on March 1. The company’s common stock will continue to trade on Nasdaq under the symbol (VRPX) and will begin trading on a split-adjusted basis when the Nasdaq opens on March 1.